Valuation Mesa Laboratories, Inc.
Stocks
MLAB
US59064R1095
Medical Equipment, Supplies & Distribution
|
Market Closed -
Nasdaq
04:00:00 16/09/2026 HKT
|
5-day change | 1st Jan Change | ||
| 127.15 USD | +4.67% |
|
+2.76% | +61.97% |
| 08-11 | Mesa Laboratories, Inc., Q1 2027 Earnings Call, Aug 10, 2026 | |
| 08-11 | Tranche Update on Mesa Laboratories, Inc.'s Equity Buyback Plan announced on November 10, 2005. | CI |
Company Valuation: Mesa Laboratories, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: March | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|
| Market Cap 1 | 1,337 | 934.1 | 591.9 | 644.8 | 488.5 | 711.5 | - |
| Change | - | -30.14% | -36.64% | 8.93% | -24.23% | 45.65% | - |
| Enterprise Value (EV) | 1,506 | 1,084 | 591.9 | 644.8 | 488.5 | 711.5 | 711.5 |
| Change | - | -27.99% | -45.42% | 8.93% | -24.23% | 45.65% | 0% |
| P/E | 728x | 1,028x | -2.32x | -330x | 73.1x | 57.6x | 38.1x |
| PBR | 3.41x | 2.38x | 4.07x | 4.05x | 2.62x | 3.64x | 3.31x |
| PEG | - | -20x | 0x | 3.3x | -0x | 0.7x | 0.7x |
| Capitalization / Revenue | 7.25x | 4.26x | 2.74x | 2.68x | 1.96x | 2.79x | 2.63x |
| EV / Revenue | 0x | 0x | 0x | 0x | 0x | 2.79x | 2.63x |
| EV / EBITDA | 0x | 0x | 0x | 0x | 0x | 11.5x | 10.4x |
| EV / EBIT | 0x | 0x | 0x | 0x | 0x | 11.8x | 10.8x |
| EV / FCF | 0x | 0x | 0x | 0x | 0x | 16x | 15.2x |
| FCF Yield | 2.6% | 2.51% | 7.02% | 6.6% | 8.1% | 6.24% | 6.56% |
| Dividend per Share 2 | 0.64 | 0.64 | 0.64 | 0.64 | 0.64 | 0.64 | 0.64 |
| Rate of return | 0.25% | 0.37% | 0.58% | 0.54% | 0.72% | 0.5% | 0.5% |
| EPS 2 | 0.35 | 0.17 | -47.2 | -0.36 | 1.21 | 2.207 | 3.34 |
| Distribution rate | 183% | 376% | -1.36% | -178% | 52.9% | 29% | 19.2% |
| Net sales 1 | 184.3 | 219.1 | 216.2 | 241 | 249.1 | 255.3 | 270.3 |
| EBITDA 1 | 41.16 | 49.68 | 50.5 | 56.74 | 63.49 | 62 | 68.45 |
| EBIT 1 | 37.9 | 45.82 | 50.5 | 51.36 | 58.23 | 60.5 | 65.9 |
| Net income 1 | 1.871 | 0.93 | -254.2 | -1.974 | 6.712 | 13.27 | 21.13 |
| Net Debt | 169 | 150.4 | - | - | - | - | - |
| Reference price 2 | 254.88 | 174.73 | 109.73 | 118.66 | 88.42 | 127.15 | 127.15 |
| Nbr of stocks (in thousands) | 5,246 | 5,346 | 5,394 | 5,434 | 5,525 | 5,596 | - |
| Announcement Date | 31/5/22 | 25/5/23 | 5/6/24 | 28/5/25 | 27/5/26 | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 57.62x | - | - | 0.5% | 712M | |
| 28.91x | 3.99x | 15.44x | 2.52% | 177B | |
| 19.83x | 3.61x | 12.9x | 3% | 120B | |
| 17.7x | 0.21x | 12.92x | 0.74% | 61.69B | |
| 35.83x | 3.45x | 11.82x | 2.11% | 50.64B | |
| 27.35x | 6.71x | 17.3x | 1.46% | 48.16B | |
| 34.65x | 6.09x | 19.13x | -.--% | 32.62B | |
| 41.45x | 1.23x | 11.35x | 0.23% | 28.17B | |
| 42.56x | 7.46x | 26.77x | 0.25% | 25.69B | |
| 16.71x | 2.66x | 9.44x | 1.66% | 21.33B | |
| Average | 32.26x | 3.94x | 15.23x | 1.25% | 56.55B | |
| Weighted average by Cap. | 27.40x | 3.77x | 14.76x | 1.9% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- MLAB Stock
- Valuation Mesa Laboratories, Inc.
Select your edition
All financial news and data tailored to specific country editions
